Lounsbury Highlighted in Forbes Article about UVM Medicinal Marijuana Course
July 21, 2017 by
Karen Lounsbury, Ph.D., pharmacology professor of and researcher
"Considering the ongoing impact of the opioid epidemic and cannabis' potential as both a major industry and a safer, often far cheaper treatment for various medical conditions, Lounsbery's small risk in bringing cannabis science to academia seems like the right kind to take: Thoughtful, constructive, and evidence-based." - Janet Burns, Forbes
In a July 21, 2018 Forbes
article about UVM's medicinal marijuana course "Cannabis Past, Present, and Future," UVM Professor of Pharmacology and co-designer of the class, Karen Lounsbury, Ph.D., spoke about the structure of the course, the red tape involved in researching cannabis materials, and cannabis as a potential replacement pain-killer for opioid patients.
Read the full article at Forbes.com.